Amydis, Inc.
Los Angeles, US · Delaware corporation · 1 known investors
Amydis develops proprietary ocular tracers that detect molecular biomarkers for diseases of the eye, heart, and brain through non-invasive eye-based testing. It builds a multi-omics data warehouse and AI-enabled health insights to support earlier diagnosis and precision treatment.
Founders & leadership
SS
Stella SarrafFounder
JK
James KhodabakhshNamed on SEC filing
MT
Mervyn TurnerNamed on SEC filing
FC
Faith CharlesNamed on SEC filing
Board
CA)
Investors · 1
Reported raises · per SEC filings
Form D private placements$14.7M disclosed across 3 rounds · 2022–2023
▶$3MraisedDec 2023 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christine AylwardDirector
- Mervyn TurnerDirector
- Stella SarrafExecutive Officer, Director
- James KhodabakhshDirector
- Jerre L. SteadDirector
- Jack Thrift, CPAExecutive Officer
- Offering amount
- $6M
- Amount sold
- $3M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedDec 2022 · 2 investors · BiotechnologyRule 506(b)
▶$6MraisedDec 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mervyn TurnerDirector
- Jerre L. SteadDirector
- Christine AylwardDirector
- James KhodabakhshDirector
- Stella SarrafExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $6M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedApr 2022 · 14 investors · BiotechnologyRule 506(b)
▶$5.7MraisedApr 2022 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stella SarrafExecutive Officer, Director
- James KhodabakhshDirector
- Mervyn TurnerDirector
- Christine AylwardDirector
- Faith CharlesDirector
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Doximity28 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Practo14 shared keywordsPracto is a healthcare platform offering online video consultations with verified doctors across specialties and appointment booking for in-clinic visits. It serves patients in India, connecting them with doctors across areas such as dentistry, gynecology, pediatrics, and general medicine.
Sharecare9 shared keywordsSharecare operates a digital health platform that helps employees, health plan members, and patients manage their health, navigate care, and optimize benefits. Its offerings include health tracking, evidence-based digital therapeutics, personalized care navigation and advocacy, and in-home caregiving services via CareLinx.
Companies competing with Amydis, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Amydis, Inc. do?
- Amydis develops proprietary ocular tracers that detect molecular biomarkers for diseases of the eye, heart, and brain through non-invasive eye-based testing. It builds a multi-omics data warehouse and AI-enabled health insights to support earlier diagnosis and precision treatment.
- Who founded Amydis, Inc.?
- Amydis, Inc. was founded by Stella Sarraf.
- Who are Amydis, Inc.'s investors?
- Amydis, Inc.'s investors include Magnetic Ventures.
- How much funding has Amydis, Inc. raised?
- Amydis, Inc. has disclosed $14.7M raised across 3 rounds.
- Where is Amydis, Inc. headquartered?
- Amydis, Inc. is headquartered in Los Angeles, US.